Microplate-based automatic blood grouping analyzer Metis of Aikang MedTech Co., Ltd. (henceforth referred to as Aikang) received approval for marketing in 2015; and its MGT-based automatic blood grouping analyzer Aigel received approval for marketing in 2016.

Themed "Global IVD Innovation & Cross-Regional Integration," this groundbreaking event brings together distinguished experts from around the world to explore the future of diagnostics.

The US Food and Drug Administration this week granted Emergency Use Authorization for LG Chem's AdvanSure SARS-CoV-2 IgG(RBD) ELISA COVID-19 antibody test.

Thermo Fisher Scientific and Qatar Genome Program, a member of the Qatar Foundation, have announced a partnership to use custom genotyping arrays to accelerate genomic research and the clinical applications of predictive genomics in Qatar.

Suzhou Bangqi Biotechnology Co., Ltd.（translated from company’s Chinese name） completed tens of millions of yuan in Series A financing, laying out the field of self-free & allergy diagnosis

The Food and Drug Administration’s Center for Devices and Radiological Health plans to start accepting pre-submission requests for in vitro diagnostics starting on June 1, including for tests not related to COVID-19.

A study of 1.3 million women in England has provided evidence to support the extension of cervical cancer screening intervals from three years to five years for those that have a negative screen result.

Those working in the industry will be aware that the implementation of the IVDR has been far from straightforward, and that there is still a lot of work to be done.

This is the 68th edition of our annual ranking of America’s largest companies, and it was a blowout year for the companies featured—despite rising inflation, the ongoing supply chain crisis, and the second year of the COVID-19 pandemic.

Cardiff site will manufacture single-use bioprocessing technologies used to make vaccines and biopharmaceuticals for global customers.

Chinese precision oncology firm Burning Rock Biotech reported on Tuesday that its first quarter 2022 revenues were up 27 percent year over year.

On May 26, 2022, the team of Xiamen University, Hong Kong University, Wantai Biopharm and China National Institute for Food and Drug Control published online research results.